Assessing Knowledge, Attitude, and Practice (KAP) towards Monkeypox among Healthcare Workers in JORDAN: A Cross-Sectional Survey
-
Published:2024-06-25
Issue:2
Volume:17
Page:254-266
-
ISSN:2707-6253
-
Container-title:Jordan Journal of Pharmaceutical Sciences
-
language:
-
Short-container-title:Jordan j. pharm. sci.
Author:
AlBalas Samir,AlMaqableh Hindya O.,Al Smadi Audai Naji,Omari Dana A.,Odeibat Aram M.,AlBalas Mustafa
Abstract
Introduction: The zoonotic features and potential for transmission between animals and humans make the monkeypox (MPX) virus, a member of the orthopoxvirus family, a serious threat. Unfortunately, healthcare staff's lack of knowledge and readiness about MPX has made it harder to implement effective prevention and response plans. Our current understanding of the KAPs (Knowledge, Attitudes, and Practices) among Jordanian clinicians could benefit from additional research.
Methods: This cross-sectional study aimed to evaluate the MPX KAP among 300 healthcare workers (HCWs) in two private hospitals in the Irbid governorate of Jordan. We employed descriptive statistics, such as percentages and frequencies, as well as an independent sample t-test, one-way ANOVA, and multiple linear regression (enter method) for data analysis.
Results: Although differences existed between demographic groups, the study found that participants had an average level of MPX knowledge proficiency. Out of a total of 300 participants, 196 were female and 104 were male, with 52.7% in the 20–30 age bracket. Compared to their female counterparts, male respondents exhibited higher levels of knowledge, attitudes, and practices regarding MPX. Attitudes and practices towards MPX varied by age group and level of education, demonstrating how demographic factors impact these aspects of public health. Additionally, monkeypox attitudes were lower among women, those with a diploma degree, and those aged 31–40.
Conclusions: Healthcare staff require adequate training and continuous education to address their lack of knowledge and attitudes regarding MPX protection. Staying updated about new illnesses like MPX is crucial, as the COVID-19 pandemic demonstrated. To effectively tackle global health concerns, continuous learning and up-to-date knowledge are essential.
Publisher
The University of Jordan
Reference51 articles.
1. Abdelaal, A., Reda, A., Lashin, B. I., Katamesh, B. E., Brakat, A. M., AL-Manaseer, B. M., Kaur, S., Asija, A., Patel, N. K., Basnyat, S., Rabaan, A. A., Alhumaid, S., Albayat, H., Aljeldah, M., Shammari, B. R. A., Al-Najjar, A. H., Al-Jassem, A. K., AlShurbaji, S. T., Alshahrani, F. S., … Sah, R. Preventing the Next Pandemic: Is Live Vaccine Efficacious against Monkeypox, or Is There a Need for Killed Virus and mRNA Vaccines? Vaccines. 2022; 10(9):1–13. 2. https://doi.org/10.3390/vaccines10091419 3. Brown, K., and Leggat, P. A. Human monkeypox: Current state of knowledge and implications for the future. Tropical Medicine and Infectious Disease. 2016; 1(1): 1–13. https://doi.org/10.3390/tropicalmed1010008 4. Dada, E. G., Oyewola, D. O., Joseph, S. B., Emebo, O., & Oluwagbemi, O. O. Ensemble Machine Learning for Monkeypox Transmission Time Series Forecasting. Applied Sciences (Switzerland). 2022; 12(23). 5. https://doi.org/10.3390/app122312128
|
|